AzTrials
AzTrials

Spatial NeglectCogSpa-VRNCT05723146

Spatial Cognition Assessment in Virtual Reality

A study testing Spatial cognition assessment in people with Spatial Neglect, run by Université Paris Cité at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Unilateral spatial neglect (USN) is a highly-prevalent neuropsychological syndrome following a cerebral stroke characterized by massive impairments in daily life. The evaluation and the rehabilitation of USN encounter many limits whereas immersive virtual reality (VR) could be an efficient tool to go through these… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Spatial Neglect
What is being tested?
Spatial cognition assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
1 Jan 2022to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • unilateral right stroke

Who cannot join

  • epilepsy / migraine
  • craniotomy
  • major sensory/motor deficit
  • severe cognitive impairment

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Université Paris Cité

    Paris

    Alma Guilbert

    Recruiting

Other trials in France

About this study

Unilateral spatial neglect (USN) is a highly-prevalent neuropsychological syndrome following a cerebral stroke characterized by massive impairments in daily life. The evaluation and the rehabilitation of USN encounter many limits whereas immersive virtual reality (VR) could be an efficient tool to go through these limits by imitating an environment of perception and action very close to the real one. The investigators will test a multisensory battery of evaluation based on VR for the diagnostic of USN.

Conditions
Spatial Neglect
Being tested
Spatial cognition assessment
Keywords
spatial neglect, virtual reality, assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spatial cognition assessmentBehavioural

    The intervention will be composed of tasks assessing spatial cognition in a real environment (cancellation task, line bisection and baking tray task) and in a virtual environment (cancellation task, line bisection, baking tray task and localization tasks).The Catherine Bergego Scale (questionnaire) will also be used.

Study groups in NCT05723146
Study groupRoleWhat they receive
Spatial cognition assessmentExperimentalA single session of spatial cognition assessment (baseline) will be proposed to participants. This assessment will be based on paper-and-pencil tasks and immersive virtual reality tasks (with an HTC Vive Pro Head-Mounted-Display). The assessment will last around 1 hour.
Receives: Behavioral: Spatial cognition assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Omissions in cancellation tasks

    Number and localization in space

    Measured: Baseline

  2. Deviation in line bisection tasks

    Deviation of the bisection from the true center of the lines (in mm)

    Measured: Baseline

  3. Number of the cubes in each side of space in the Baking Tray Tasks

    16 cubes have to be disposed

    Measured: Baseline

  4. Detections in the localization tasks

    Number and localization in space

    Measured: Baseline

Secondary outcomes (3)
  1. Duration of eye fixation in each side of space during VR tasks

    Collected thanks to the VR headset

    Measured: Baseline

  2. Completion time of each task

    (in s)

    Measured: Baseline

  3. Score in the Catherine Bergego Scale (CBS)

    Functional assessment scored by the occupational therapists. Minimum: 0 / Maximum: 30 / Higher scores mean a better outcome

    Measured: Assessed within the same week as Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2023
  2. Study start1 Jan 2022
  3. Primary completion1 Jan 2023
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Model description
60 patients with right stroke will be included in this study: a group of 30 patients with USN will be compared to a group of 30 patients without USN.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05723146
Sponsor's protocol ID
CogSpa-VR
Acronym
CogSpa-VR
Status last verified
May 2024
First submitted
3 Jan 2023
Last updated
8 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Spatial cognition assessment in people with Spatial Neglect, run by Université Paris Cité at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alma Guilbert, PhD (+33176533178, alma.guilbert@u-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Omissions in cancellation tasks (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in